rs34682912

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_000542.5(SFTPB):​c.291G>A​(p.Glu97Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00295 in 1,613,860 control chromosomes in the GnomAD database, including 38 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0027 ( 5 hom., cov: 32)
Exomes 𝑓: 0.0030 ( 33 hom. )

Consequence

SFTPB
NM_000542.5 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.123

Publications

2 publications found
Variant links:
Genes affected
SFTPB (HGNC:10801): (surfactant protein B) This gene encodes the pulmonary-associated surfactant protein B (SPB), an amphipathic surfactant protein essential for lung function and homeostasis after birth. Pulmonary surfactant is a surface-active lipoprotein complex composed of 90% lipids and 10% proteins which include plasma proteins and apolipoproteins SPA, SPB, SPC and SPD. The surfactant is secreted by the alveolar cells of the lung and maintains the stability of pulmonary tissue by reducing the surface tension of fluids that coat the lung. The SPB enhances the rate of spreading and increases the stability of surfactant monolayers in vitro. Multiple mutations in this gene have been identified, which cause pulmonary surfactant metabolism dysfunction type 1, also called pulmonary alveolar proteinosis due to surfactant protein B deficiency, and are associated with fatal respiratory distress in the neonatal period. Alternatively spliced transcript variants encoding the same protein have been identified.[provided by RefSeq, Feb 2010]
SFTPB Gene-Disease associations (from GenCC):
  • surfactant metabolism dysfunction, pulmonary, 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (REVEL=0.033).
BP6
Variant 2-85666719-C-T is Benign according to our data. Variant chr2-85666719-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 165205.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.123 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00274 (417/152180) while in subpopulation SAS AF = 0.00622 (30/4824). AF 95% confidence interval is 0.00448. There are 5 homozygotes in GnomAd4. There are 197 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 5 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000542.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SFTPB
NM_000542.5
MANE Select
c.291G>Ap.Glu97Glu
synonymous
Exon 4 of 11NP_000533.4
SFTPB
NM_198843.3
c.291G>Ap.Glu97Glu
synonymous
Exon 5 of 12NP_942140.3P07988
SFTPB
NM_001367281.1
c.291G>Ap.Glu97Glu
synonymous
Exon 4 of 9NP_001354210.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SFTPB
ENST00000519937.7
TSL:1 MANE Select
c.291G>Ap.Glu97Glu
synonymous
Exon 4 of 11ENSP00000428719.2P07988
SFTPB
ENST00000393822.7
TSL:1
c.291G>Ap.Glu97Glu
synonymous
Exon 5 of 12ENSP00000377409.4P07988
SFTPB
ENST00000409383.7
TSL:1
c.291G>Ap.Glu97Glu
synonymous
Exon 5 of 12ENSP00000386346.2

Frequencies

GnomAD3 genomes
AF:
0.00275
AC:
418
AN:
152062
Hom.:
5
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000652
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00249
Gnomad ASJ
AF:
0.0245
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00601
Gnomad FIN
AF:
0.000471
Gnomad MID
AF:
0.0348
Gnomad NFE
AF:
0.00303
Gnomad OTH
AF:
0.00766
GnomAD2 exomes
AF:
0.00384
AC:
965
AN:
251296
AF XY:
0.00431
show subpopulations
Gnomad AFR exome
AF:
0.000246
Gnomad AMR exome
AF:
0.00231
Gnomad ASJ exome
AF:
0.0185
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.000278
Gnomad NFE exome
AF:
0.00345
Gnomad OTH exome
AF:
0.00587
GnomAD4 exome
AF:
0.00297
AC:
4345
AN:
1461680
Hom.:
33
Cov.:
35
AF XY:
0.00322
AC XY:
2344
AN XY:
727170
show subpopulations
African (AFR)
AF:
0.00134
AC:
45
AN:
33478
American (AMR)
AF:
0.00257
AC:
115
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
0.0177
AC:
462
AN:
26118
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.00777
AC:
670
AN:
86258
European-Finnish (FIN)
AF:
0.000300
AC:
16
AN:
53366
Middle Eastern (MID)
AF:
0.0283
AC:
163
AN:
5766
European-Non Finnish (NFE)
AF:
0.00231
AC:
2563
AN:
1111902
Other (OTH)
AF:
0.00513
AC:
310
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
251
501
752
1002
1253
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
96
192
288
384
480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00274
AC:
417
AN:
152180
Hom.:
5
Cov.:
32
AF XY:
0.00265
AC XY:
197
AN XY:
74394
show subpopulations
African (AFR)
AF:
0.000650
AC:
27
AN:
41518
American (AMR)
AF:
0.00248
AC:
38
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.0245
AC:
85
AN:
3472
East Asian (EAS)
AF:
0.000194
AC:
1
AN:
5164
South Asian (SAS)
AF:
0.00622
AC:
30
AN:
4824
European-Finnish (FIN)
AF:
0.000471
AC:
5
AN:
10618
Middle Eastern (MID)
AF:
0.0306
AC:
9
AN:
294
European-Non Finnish (NFE)
AF:
0.00303
AC:
206
AN:
67976
Other (OTH)
AF:
0.00758
AC:
16
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
28
55
83
110
138
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00334
Hom.:
2
Bravo
AF:
0.00260
Asia WGS
AF:
0.00462
AC:
16
AN:
3478
EpiCase
AF:
0.00453
EpiControl
AF:
0.00468

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
2
not specified (2)
-
-
1
Hereditary pulmonary alveolar proteinosis (1)
-
-
1
Surfactant metabolism dysfunction, pulmonary, 1 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
1.8
DANN
Benign
0.47
PhyloP100
-0.12
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34682912; hg19: chr2-85893842; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.